Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Read More
Phase 3 clinical trials of new breast cancer treatment approved in the U.S. and Europe will be conducted in Korea. The clinical trial is a global trial that will be conducted in multiple countries and is expected to be supplied in Korea as some Korea ...
